Persistent Risk of Severe Covid-19 in Heart Transplant Recipients: A National Cohort Study

PURPOSE: Vaccination and therapeutic monoclonal antibodies (mAb) provide high protection against severe forms of SARS-CoV-2 infection (COVID-19) in the general population. In France, vaccination campaign started on December 2020 and the first mAb was approved on August 2021. This national cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Legeai, C., Abdoul, N., Jasseron, C., Battistella, P., Nubret, K., Kerbaul, F., Dorent, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
(412)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068033/
http://dx.doi.org/10.1016/j.healun.2023.02.427

Ejemplares similares

Ejemplares similares